Francisco Caiado
Francisco Caiado
1Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal
1,✉,
Diogo Maia-Silva
Diogo Maia-Silva
1Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal
2Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY USA
1,2,
Carolina Jardim
Carolina Jardim
1Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal
1,
Nina Schmolka
Nina Schmolka
1Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal
3Department of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland
1,3,
Tânia Carvalho
Tânia Carvalho
1Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal
1,
Cláudia Reforço
Cláudia Reforço
1Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal
1,
Rita Faria
Rita Faria
1Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal
1,
Branka Kolundzija
Branka Kolundzija
1Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal
1,
André E Simões
André E Simões
1Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal
1,
Tuncay Baubec
Tuncay Baubec
3Department of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland
3,
Christopher R Vakoc
Christopher R Vakoc
2Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY USA
2,
Maria Gomes da Silva
Maria Gomes da Silva
4Instituto Portugues de Oncologia—Francisco Gentil, Lisbon, Portugal
4,
Markus G Manz
Markus G Manz
5Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zürich, Switzerland
5,
Ton N Schumacher
Ton N Schumacher
6Netherlands Cancer Institute, Amsterdam, The Netherlands
6,
Håkan Norell
Håkan Norell
1Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal
1,✉,
Bruno Silva-Santos
Bruno Silva-Santos
1Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal
1,✉
1Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal
2Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY USA
3Department of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland
4Instituto Portugues de Oncologia—Francisco Gentil, Lisbon, Portugal
5Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zürich, Switzerland
6Netherlands Cancer Institute, Amsterdam, The Netherlands
Subject terms: Biological models, Cancer models, Cancer, Cancer stem cells, Tumour heterogeneity
© The Author(s) 2019
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
